TIRZEPATIDE IS ASSOCIATED WITH IMPROVED METABOLIC OUTCOMES IN PEOPLE WITH TYPE 1 DIABETES AND OVERWEIGHT OR OBESITY: A RETROSPECTIVE COHORT STUDY